The DEK oncoprotein and its emerging roles in gene regulation

Leukemia
Carl Sandén, Urban Gullberg

Abstract

The DEK oncogene is highly expressed in cells from most human tissues and overexpressed in a large and growing number of cancers. It also fuses with the NUP214 gene to form the DEK-NUP214 fusion gene in a subset of acute myeloid leukemia. Originally characterized as a member of this translocation, DEK has since been implicated in epigenetic and transcriptional regulation, but its role in these processes is still elusive and intriguingly complex. Similarly multifaceted is its contribution to cellular transformation, affecting multiple cellular processes such as self-renewal, proliferation, differentiation, senescence and apoptosis. Recently, the roles of the DEK and DEK-NUP214 proteins have been elucidated by global analysis of DNA binding and gene expression, as well as multiple functional studies. This review outlines recent advances in the understanding of the basic functions of the DEK protein and its role in leukemogenesis.

References

Oct 1, 1992·Baillière's Clinical Haematology·M von LindernG Grosveld
Oct 1, 1983·Cancer Genetics and Cytogenetics·K VermaelenH Van den Berghe
Oct 1, 1983·Cancer Genetics and Cytogenetics·S SchwartzM M Cohen
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·G K FuD M Markovitz
Jan 22, 2000·Arthritis and Rheumatism·X DongW H Reeves
Feb 26, 2000·Clinical and Experimental Immunology·I WichmannA Nuñez-Roldan
Mar 1, 2000·Trends in Biochemical Sciences·L Aravind, E V Koonin
May 9, 2002·The Journal of Biological Chemistry·Tanja WaldmannClaudia Gruss
Feb 22, 2003·Nucleic Acids Research·Mónica CampillosJesús Vázquez
Jun 26, 2003·Arthritis Research & Therapy·Barbara S AdamsDavid M Markovitz
Jul 24, 2003·The American Journal of Pathology·Marta Sanchez-CarbayoCarlos Cordon-Cardo
Nov 25, 2003·Nucleic Acids Research·Tanja WaldmannClaudia Gruss
Jan 24, 2004·Leukemia & Lymphoma·Sílvia CasasSakari Knuutila
Jun 17, 2004·Molecular and Cellular Biology·Ferdinand KappesTanja Waldmann
Jun 17, 2004·Molecular and Cellular Biology·Ferdinand KappesClaudia Gruss
Sep 15, 2004·American Journal of Clinical Pathology·Mauricio P OyarzoL Jeffrey Medeiros
Jul 1, 2005·The Journal of Biological Chemistry·Joanne ClearyDavid M Markovitz
Sep 24, 2005·Genes, Chromosomes & Cancer·Marija OrlicBrenda L Gallie
Apr 11, 2006·The Journal of Biological Chemistry·Erica CavellánAnn-Kristin Ostlund Farrants
May 25, 2006·Cell Cycle·Maria Stella CarroHeiko Müller
Jul 1, 2006·Science·Luis Miguel Mendes SoaresJuan Valcárcel
Jul 11, 2006·The Journal of Biological Chemistry·Morgan SammonsBrian P Ashburner
Aug 9, 2006·Molecular and Cellular Biology·Trisha M Wise-DraperSusanne I Wells
Oct 13, 2006·Molecular and Cellular Biology·Nirit Mor-VakninDavid M Markovitz
May 26, 2007·Biochemical and Biophysical Research Communications·Hong-gang HuRolf Knippers
May 29, 2007·Nature Structural & Molecular Biology·Matthew J Gamble, Robert P Fisher
Sep 15, 2007·Molecular Cancer Research : MCR·Martín C AbbaC Marcelo Aldaz
Mar 12, 2008·Molecular and Cellular Biology·F KappesE Ferrando-May
Nov 28, 2008·The American Journal of Pathology·Trisha M Wise-DraperSusanne I Wells
Feb 19, 2009·Cancer Research·Trisha M Wise-DraperSusanne I Wells
Feb 21, 2009·Journal of Cellular Biochemistry·Dong-Wook KimSang-Beom Seo
Jul 1, 2009·Pathology International·Songying HanZhenhua Lin
Aug 15, 2009·Cancer Research·Michael S KhodadoustMaría S Soengas
Aug 22, 2009·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Hideaki TakataKei-Ichi Shibahara
Dec 31, 2009·Genes & Development·Shun SawatsubashiShigeaki Kato

❮ Previous
Next ❯

Citations

Nov 23, 2017·Nucleic Acids Research·Jennifer A BohnAaron C Goldstrohm
Aug 26, 2015·Molecular and Cellular Biology·Felix LohmannJames J Bieker
Mar 18, 2017·Current Opinion in Hematology·Maegan L Capitano, Hal E Broxmeyer
Feb 27, 2018·F1000Research·Jonathan NyeYamini Dalal
May 2, 2020·Nature Reviews. Urology·Zhiwei WangWenyi Wei
Jul 4, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Tianda FengHeng Cai
Jan 24, 2019·Cells·Adélia Mendes, Birthe Fahrenkrog
Nov 27, 2019·International Journal of Molecular Sciences·Kam-Fai LeeKwang-Huei Lin
Jul 9, 2020·Cancers·Valeria PietropaoloUgo Moens
Mar 29, 2021·The New Phytologist·Wei ZongSibum Sung
May 29, 2021·The American Journal of Surgical Pathology·Lisa M RooperJustin A Bishop

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.